Dr Trieu is a leading expert in global food policy and sodium reduction, currently serving as the Co-Director of the World Health Organization Collaborating Centre on Population Salt Reduction at The George Institute for Global Health. With a distinguished career in public health, Dr Trieu has advanced nutrition policies and programs aimed at reducing diet-related diseases worldwide, particularly among disadvantaged populations.

Dr Trieu holds a PhD in Medicine from The University of Sydney, Australia and has received several prestigious fellowships, including the NHMRC Early Career Fellowship and the National Heart Foundation of Australia Postdoctoral Fellowship.

As Program Lead - Nutrition Implementation Research at The George Institute, Dr Trieu plays a pivotal role in shaping effective food policies and innovative nutrition programs. Her work focuses on the practical application and implementation of evidence-based nutrition approaches. This includes leading a program of work to change the world’s salt supply from regular to potassium-enriched salt as a strategy to reduce cardiovascular diseases.  As well as developing and adapting Food is Medicine programs for disadvantaged communities in Australia. Her expertise extends internationally, providing guidance and support to many low- and middle-income countries in implementing evidence-based strategies for better health outcomes.

In addition to her research, Dr Trieu serves as a Conjoint Senior Lecturer at the Faculty of Medicine, The University of New South Wales, where she contributes to the academic development of future public health leaders.

Dr Trieu continues to make significant impact on improving global nutrition and reducing the burden of diet-related diseases through strategic policy and research.

Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia and Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London.

After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.  

Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium.  Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.

Deepika comes from an interdisciplinary background with science, management and policy degrees and holds a PhD in Public Health Policy from IIM Ahmedabad, India. Deepika holds widespread experience in consulting with various national and international development sector organisations namely UNICEF, UHC2030, Institute of Tropical Medicine, Antwerp and Oxford Policy Management, India. Her work over the past decade has been focused on the intersection of health and gender, including healthcare for the frontline workforce, SRHR with a specific focus on adolescents and sustainable menstruation, mental health, women leadership and unpacking laws and regulations from the citizen's rights perspective.

Deepika writes on public health issues and her experiences as an emerging global health researcher, questioning the regressive social norms and systems, particularly for women, demanding for equitable and responsive health and social policies in India. Deepika is an Emerging Voice for Global Health (EV4GH 2016), co-founder and current chair of the Women in Global Health India Chapter and is a strong advocate of Diversity, Equity, and Inclusion in all spaces. Some of her short pieces can be accessed here, and here. Her recent podcast with Arthan Careers in Conversations of Change, where she reflects on her journey and women’s leadership in global health can be watched here.

At the George Institute, Deepika is currently working with the Global Thought Leadership Program, supporting with strategic thinking towards strengthening the visibility of The George Institute’s work regionally and globally. She is also managing Ubuntu Initiative focused on building equitable partnerships in Africa, focused on research, capacity strengthening, and impact and engagement.

Min Jun is Scientia Associate Professor and Program Lead at the George Institute for Global Health, Faculty of Medicine, UNSW Sydney.

Min leads a program of research focused on understanding the impact of clinical management strategies in people with kidney disease and its related complications. He has developed and leads international projects using large clinical trial and real-world, population based data sources.

Min holds a PhD (2012) and MScMed(ClinEpi) in clinical epidemiology from the University of Sydney, and a MSc(by research) and BSc(Hon) from UNSW Sydney. He was previously an NHMRC Early Career Fellow (2013-2016) based in Canada (University of Calgary), co-funded by two additional competitive federal/provincial Canadian fellowships (CIHR/AIHS). Min's research track record includes >100 publications (including in top-ranked journals e.g. BMJ, Lancet, JACC), >$5.1M in research funding from top-level funding agencies (e.g. NHMRC). To date, 72% of his work is published in top 10% journals worldwide, has been cited >4500 times including in some 24 international clinical practice guidelines across various fields.

Min is actively involved in mentoring, training and supervising research students and fellows. He currently serves as Associate Editor (Global Health) for Kidney and Blood Pressure Research and has been involved in the development of clinical practice guidelines for the care of patients with kidney disease in Australia and internationally.

Dr Anna Campain is a biostatistician with experience in health, medical and bioinformatics research.

She has worked extensively with routinely-collected health data, both linked and non-linked. Anna has a special interest in using routinely-collected health datasets to explore and understand health patterns in high-risk or vulnerable populations to inform treatments, approaches and behaviours. She is passionate about research that will be translated to end-user benefit through changes in clinical guidelines, health policy and resource management.

Joining The George Institute for Global Health in 2018, Anna brings over a decade of experience in applied statistics. As an applied statistician, Anna is passionate about using robust, appropriate and contemporary statistical methods to investigate clinically important research questions. Her experience to date has involved the application of advanced regression methods and machine learning techniques to chronic disease research, the use of accessible data visualisation methods to disseminate findings to a wide research audience, and regional, state and national health program evaluation and impact investigations.

Damian Maganja is a Research Fellow in the Food Policy Division. His work looks at policies and processes to improve the healthiness of food environments, with a focus on better regulation and governance of harmful products and industries.

Damian joined the academic sector after working in health policy and programs with various government and non-government organisations. He holds a Doctor of Philosophy (Medicine) from the University of New South Wales and a Master of International Public Health and a Bachelor of Economics and Social Sciences (Political Economy), both from the University of Sydney.

Sarah is Chief People Officer at The George Institute. She is an established executive People & Culture leader who has broad international experience and a successful track record of over 20 years spent in the corporate, professional and financial services sectors.

Sarah is skilled in articulating purpose and vision and in designing and executing strategies to improve organisational effectiveness. She is passionate about working at the leadership level to transform and realise the potential of an organisation through its people, purpose and vision. 

Recognised as a change agent, Sarah is able to transform team and business performance within HR and across businesses. Her customer-centred approach is combined with a strong commitment to teamwork, integrity and respect.

Sarah holds a BA (Psychology & Social Policy) and Masters of Industrial Relations & HR Management. She is a Member of the Australian Institute of Company Directors. 

Dennis Mazingi is a medical doctor and general surgeon with a special interest in paediatric injury prevention, global surgery, and surgically correctable NCDs. He has worked in clinical medicine and surgery in southern Africa for almost a decade and is currently pursuing a DPhil in the University of Oxford’s Nuffield Department of Surgical Sciences in the global surgery group.

His work focuses on trauma surveillance and quality improvement in paediatric trauma care in Zimbabwe. He is ably supervised by Professor Kokila Lakhoo and Professor Ashok Handa at the Nuffield Department of Surgical Sciences and Professor Godfrey Muguti at the University of Zimbabwe.

Prior to joining The George Institute Dennis obtained his undergraduate medical degree at the University of Malawi, College of Medicine and an MMed (Master’s in Medicine) in General Surgery at the University of Zimbabwe, College of Health Sciences. He holds a first-class degree in International Health and Tropical Medicine (IHTM) from the University of Oxford and is a fellow of the College of Surgeons of South Africa as well as a Beit Trust Scholar.

He has worked in various research collaboratives in the field of global surgery, paediatric surgery, and general surgery. Dennis’s other interests lie in clinical surgery, surgical education, disruptive health technologies, frugal innovations, health systems and implementation research.

Dennis wants to see a healthier, more prosperous, more equitable world through surgical care and research. His mission is to help accelerate progress towards SDG target 3.6: to halve the number of deaths and injuries from road traffic accidents by 2030 in Zimbabwe and globally; and to scale up quality surgical and anaesthesia care to the 5 billion people who need it through 2030 and beyond.

Martin is Professorial Fellow at the George Institute, Head of the South Western Sydney Campus for the Faculty of Medicine & Health at UNSW, and a clinical nephrologist at Liverpool Hospital.

He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.

Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), measurement of health systems and applying research evidence into clinical practice.

Ms Sarah Coggan is a Senior Project Manager at the George Institute for Global Health (TGI) as well as for George Clinical, TGI’s commercial partner company. She has more than 15 years of experience working in clinical trials both in the academic and commercial settings.

Sarah has a science background in Pharmacology/ Communication and a Masters of Public Health. She began employment at the George Institute in July 2012 and has remained within the Renal Program, including 2 years based remotely in the United States. Her expertise lies in the implementation of pragmatic randomised clinical trials, data linkage, building collaborative relationships with commercial and academic Sponsors, and implementing corporate knowledge within future renal research activities.